U.S. Consumer Services Stock News

NYSE:BMI
NYSE:BMIElectronic

Badger Meter (BMI) Could Be 4% Undervalued As Lawsuits Cloud Demand Concerns

Badger Meter (BMI) is under scrutiny after multiple law firms launched securities class actions and investigations alleging the company misrepresented demand trends by pulling forward customer orders to support reported financial results. See our latest analysis for Badger Meter. At a share price of $140.88, Badger Meter has seen a 12.23% 1 month share price return, but its year to date share price return is down 20.13% and the 1 year total shareholder return is down 42.14%. This shows that...
NYSE:NGVT
NYSE:NGVTChemicals

Is Ingevity (NGVT) Undervalued Or Is Its Recovery Story Already Priced In?

Ingevity (NGVT) has drawn fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with fundamentals such as segment mix, recent returns and profitability trends. See our latest analysis for Ingevity. The latest move takes Ingevity's share price to $77.12, with a 1-month share price return of 11.88% and a year-to-date share price return of 28.34%. The 1-year total shareholder return of 77.86% contrasts with a 5-year total shareholder...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Is Strive (ASST) Undervalued Following Its Sharp Share Price Slide?

Strive (ASST) has drawn fresh attention after recent trading left the stock well below its past year level, with both short term moves and longer term declines prompting investors to reassess risk and potential reward. See our latest analysis for Strive. At the latest share price of $11.34, Strive’s 7 day share price return is down 23.64% and the 30 day share price return is down 36.36%, while the 1 year total shareholder return has declined 85.50%. This suggests recent momentum has been...
NYSE:VSH
NYSE:VSHElectronic

EV Stocks With Real Supply Chain Exposure Retail Investors Should Watch

Electric vehicle headlines are noisy right now, with Rivian warning that companies sticking with fossil fuel priorities may fall behind, while major automakers have written off over $70b in EV projects and US policy shifts have cooled incentives. For investors, that mix of caution and long term ambition can create mispricing, both on the upside and downside. This article looks at three stocks from an EV focused screener that are directly exposed to these news catalysts, each with potential...
NYSE:TWLO
NYSE:TWLOIT

Digital Tax Risk Could Reshape Pinterest Stock And Other US Tech Picks

Tariffs on digital services are back in the headlines, and this time the threat is a 100% levy on countries that tax large U.S. platforms like Meta, Alphabet, and Amazon. That kind of policy shock can quickly change how investors think about global exposure, profit margins, and where risk is really coming from. This article looks at three large U.S. technology stocks from a dedicated screener that are closely linked to the digital tax debate, and explains how this news could work for or...
NYSE:HGV
NYSE:HGVHospitality

Hilton Grand Vacations (HGV) Gains Momentum, Is The Stock Already Fully Valued?

Hilton Grand Vacations (HGV) has drawn fresh attention after recent trading data showed single day, week, month, and past 3 months returns all in positive territory, prompting closer scrutiny of its current valuation. See our latest analysis for Hilton Grand Vacations. At a share price of $54.69, Hilton Grand Vacations has seen momentum build, with a 90 day share price return of 44.38% and a 1 year total shareholder return of 31.15%, which together frame the current valuation debate. If this...
NYSE:WS
NYSE:WSMetals and Mining

Worthington Steel (WS) Stock Q4 Net Loss Challenges Margin Recovery Narrative

Worthington Steel (WS) has just reported FY 2026 results, with Q4 revenue of $929.2 million and a basic EPS loss of $0.98. This caps a trailing twelve month period where revenue totaled $3.4 billion and EPS came in at $0.35. Over recent quarters, the company has seen revenue move from $832.9 million and EPS of $1.13 in FY 2025 Q4 to a range between $769.8 million and $929.2 million, with EPS spanning from $0.21 to a loss of $0.98 in FY 2026. This sets a mixed backdrop for its latest release...
NYSE:ONTO
NYSE:ONTOSemiconductor

Did Analyst Buzz Around Dragonfly G5 and 4Di InSpec SR Just Shift Onto Innovation's (ONTO) Investment Narrative?

Onto Innovation recently reported fresh analyst enthusiasm around its Dragonfly G5 AI inspection platform and broader process-control portfolio, highlighting technology that targets AI-driven chip packaging and advanced node production. At the same time, subsidiary 4D Technology’s launch of the portable 4Di InSpec SR surface metrology system underscores Onto Innovation’s push into flexible, high-precision tools that serve both semiconductor and industrial customers. With the Dragonfly G5...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

MarketAxess Holdings (MKTX) Launches TraX Tape, Is The Stock Undervalued?

MarketAxess Holdings (MKTX) has drawn fresh attention after launching TraX Tape, a bond market data solution aimed at simplifying UK and EU transparency reforms while giving clients a single, cleaner view of global trading activity. See our latest analysis for MarketAxess Holdings. Despite the launch of TraX Tape and a recent quarter where MarketAxess Holdings reported year-on-year revenue and net income growth, the stock’s recent momentum has been weak. The share price is down 36.97% year to...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Is GitLab (GTLB) A Bargain After Its AI Accountability Report?

GitLab (GTLB) is in focus after releasing an AI Accountability Report showing many organizations generate AI assisted code faster than they put governance in place, raising questions about safety, reliability, and oversight. See our latest analysis for GitLab. Alongside the AI Accountability Report and a recent leadership change in its legal function, GitLab’s short term momentum has picked up, with a 90 day share price return of 42.85%, even though the year to date share price return is down...
OTCPK:CGEH
OTCPK:CGEHElectrical

Capstone Energy+ (OTCPK:CGEH) Stock Faces Lofty P/E As Recent Profitability Fuels Bullish Narratives

Capstone Energy+ (OTCPK:CGEH) has just wrapped up FY 2026 with fourth quarter revenue of US$23.0 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$106.0 million and basic EPS of US$0.14 that capture its recent move into profitability. Over the past six reported quarters, revenue has ranged between US$20.1 million and US$28.4 million per quarter, while quarterly EPS has swung from a loss of US$1.79 to a profit of US$0.06. This gives investors a clear view of how...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance

At Novavax’s 2026 Annual Meeting, nearly half of shareholders opposed the executive compensation package and there was strong opposition to three Board nominees, prompting its largest shareholder, Shah Capital, to publicly call out management’s operational shortcomings and demand urgent change. This unusually high level of shareholder pushback shines a light on governance and execution concerns that now sit alongside the company’s scientific and commercial priorities. With this backdrop of...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Could Be 58% Undervalued After BlueBird Launch Plans And Japan Venture

AST SpaceMobile (ASTS) is back in focus after announcing plans to launch its BlueBird 11, 12, and 13 satellites in early August, alongside a new direct-to-mobile joint venture in Japan. See our latest analysis for AST SpaceMobile. Despite the satellite launch cadence and new joint ventures, AST SpaceMobile’s share price has been volatile. The 1-day share price return was 8.88% after recent news, the 30-day share price return was down 44.87%, and the 1-year total shareholder return was 44.75%...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK) Stock After Recent 11% Pullback Is The Valuation Now Attractive?

With BlackRock trading at a last close of US$964.71, many investors are asking a simple question: is the stock pricing in too much optimism, or is the current level still reasonable value for the long term. Over the past week the share price declined 8.1%, adding to a 9.9% fall over the last month and an 11.1% decline year to date, even though the 3 year return sits at 49.5% and the 5 year return at 21.8%. Recent news around BlackRock has focused on its role as a major global asset manager...
NYSE:NBR
NYSE:NBREnergy Services

Can Nabors (NBR) Turn Stable Rig Demand Into a More Durable Earnings Narrative?

Nabors Industries has recently benefited from steady drilling demand and rising rig day rates in the Lower 48, helped by softer crude prices following an interim US–Iran deal and restored oil flows through the Strait of Hormuz. This combination of stable rig activity and improving day-rate economics highlights how Nabors can potentially gain even when headline oil prices soften. Next, we’ll examine how firmer rig demand and higher day rates could influence Nabors Industries’ existing...
NYSE:LHX
NYSE:LHXAerospace & Defense

What L3Harris Technologies (LHX)'s Expanded PAC‑3 Propulsion and German Comms Orders Mean For Shareholders

L3Harris Technologies recently broke ground on two additional facilities at its Arkansas Advanced Propulsion Facilities campus to expand PAC-3 missile propulsion production capacity, while also securing two Foreign Military Sales orders to supply Falcon communication systems for Germany’s D‑LBO program and special operations forces. Together, the enlarged U.S. missile propulsion footprint and new German communications orders highlight how L3Harris is deepening its role in advanced defense...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Draws Fresh Attention, Is The Valuation Gap Too Wide?

Crinetics Pharmaceuticals (CRNX) has attracted fresh attention after recent trading moves, prompting investors to reassess how its clinical-stage pipeline and current share performance might align with individual risk tolerance and time horizon. See our latest analysis for Crinetics Pharmaceuticals. Recent trading has been choppy for Crinetics Pharmaceuticals, with a 1 day share price return of 4.89% and a 90 day share price return of 9%, while the year to date share price return has declined...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

How FDA Clearance of BEAM-304’s Platform Trial for PKU May Impact Beam Therapeutics (BEAM) Investors

Beam Therapeutics announced in June 2026 that the FDA cleared its IND application for BEAM-304, an in vivo base-editing therapy delivered via intravenous lipid nanoparticles to treat phenylketonuria (PKU) by correcting mutations in the PAH gene. A distinctive element of this program is Beam’s platform-style trial design, which aims to test multiple mutation-specific base editors for PKU within a single clinical framework, reflecting the FDA’s emerging guidance to accelerate genome-editing...
NasdaqCM:ZENA
NasdaqCM:ZENASoftware

Is ZenaTech (ZENA) Undervalued After Its Green Earth Deal And Zoo Office Launch?

ZenaTech (NasdaqCM:ZENA) is back on investor radars after acquiring Florida based Green Earth Powerwashing and outlining Zoo Office, an AI powered productivity platform that broadens its reach across drone services and enterprise software. See our latest analysis for ZenaTech. The recent acquisition of Green Earth Powerwashing and the Zoo Office announcement have coincided with short term momentum in ZenaTech, with a 1 day share price return of 11.43% and a 7 day share price return of 9.86%...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Is Axsome Therapeutics (AXSM) Using Solriamfetol’s Phase 3 ADHD Trial To Redefine Its CNS Strategy?

Axsome Therapeutics has recently dosed the first patient in its FOCUS-3 Phase 3, randomized, double-blind, placebo-controlled trial of solriamfetol in adolescents aged 12 to under 18 years with ADHD, assessing six-week changes in ADHD-RS-5 total scores across approximately 468 participants. This study extends solriamfetol’s development beyond sleep-related conditions into adolescent ADHD, underlining Axsome’s push to broaden its CNS treatment footprint across multiple indications. We’ll now...
NYSE:RAMP
NYSE:RAMPSoftware

How LiveRamp’s Adobe GenStudio Integration At LiveRamp Holdings (RAMP) Has Changed Its Investment Story

On 23 June 2026, LiveRamp announced a new integration with Adobe GenStudio for Commerce Media Networks, bringing commerce purchase data into Adobe’s agentic content supply chain to help brands build and launch more targeted campaigns. The integration allows commerce media networks to form cohorts based on real purchase behavior and pair them with tailored, AI-generated creative, moving brands away from modeled audiences toward campaigns shaped by what customers have actually bought. Next,...
NasdaqGS:PPC
NasdaqGS:PPCFood

How Investors May Respond To Pilgrim's Pride (PPC) Earnings Hit From Weak Margins And Free Cash Flow

Pilgrim's Pride recently reported softer quarterly results, highlighting sluggish long-term revenue growth, low gross margins, and a shrinking free cash flow margin that point to pressure on its underlying profitability. Analysts now expect a very large year-over-year earnings decline despite only modest revenue growth, suggesting that input costs, competition, and capital intensity are weighing more heavily on the business than previously assumed. We’ll now examine how concerns over weak...
NasdaqGS:APP
NasdaqGS:APPSoftware

Does Slower Axon Adoption and Insider Selling Change The Bull Case For AppLovin (APP)?

In recent days, AppLovin has faced mixed reactions as analysts flagged slower-than-expected e-commerce client adoption for its Axon platform and insider share sales, even as the company continues to roll out new advertising tools and products. This tension between cautious near-term sentiment and an expanding AI-driven advertising suite with strong operating efficiency is now a central focus for investors assessing AppLovin’s trajectory. We’ll now examine how concerns about slower Axon and...
NYSE:ATI
NYSE:ATIAerospace & Defense

ATI (ATI) Stock After 127% One-Year Surge Is It Too Late To Buy?

If you are wondering whether ATI is still attractively priced after a strong run, the starting point is understanding what the current market price is really reflecting. The stock recently closed at US$197.40, with returns of 16.2% over the past month, 65.6% year to date and 127.4% over the last year, while the past three years show a 346.3% gain and the past five years a very large increase. Recent coverage has focused on ATI's share price performance and how investor expectations have...